Literature DB >> 21124520

Hepatitis: viral load predicts HBV recurrence after liver transplant.

Bruno Roche, Didier Samuel.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21124520     DOI： 10.1038/nrgastro.2010.165

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  11 in total

1.  Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.

Authors:  C S Coffin; P G Stock; L M Dove; C L Berg; N N Nissen; M P Curry; M Ragni; F G Regenstein; K E Sherman; M E Roland; N A Terrault
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

2.  Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006).

Authors:  Didier Samuel; Xavier Forns; Marina Berenguer; Christian Trautwein; Andrew Burroughs; Mario Rizzetto; Christian Trepo
Journal:  J Hepatol       Date:  2006-05-15       Impact factor: 25.083

Review 3.  EASL Clinical Practice Guidelines: management of chronic hepatitis B.

Authors: 
Journal:  J Hepatol       Date:  2008-10-29       Impact factor: 25.083

4.  Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation.

Authors:  B Degertekin; Steven-Huy B Han; E B Keeffe; E R Schiff; V A Luketic; R S Brown; S Emre; C Soldevila-Pico; K R Reddy; M B Ishitani; T T Tran; T L Pruett; A S F Lok
Journal:  Am J Transplant       Date:  2010-03-23       Impact factor: 8.086

5.  Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin.

Authors:  L Jiang; L Yan; B Li; T Wen; J Zhao; L Jiang; N Cheng; Y Wei; J Yang; M Xu; W Wang
Journal:  Am J Transplant       Date:  2010-08       Impact factor: 8.086

6.  Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.

Authors:  Edward J Gane; Peter W Angus; Simone Strasser; Darrell H G Crawford; John Ring; Gary P Jeffrey; Geoffrey W McCaughan
Journal:  Gastroenterology       Date:  2007-01-05       Impact factor: 22.682

7.  Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.

Authors:  Luciana C Faria; Michelle Gigou; Anne M Roque-Afonso; Mylene Sebagh; Bruno Roche; Guillaume Fallot; Teresa C A Ferrari; Catherine Guettier; Elisabeth Dussaix; Denis Castaing; Christian Brechot; Didier Samuel
Journal:  Gastroenterology       Date:  2008-03-04       Impact factor: 22.682

8.  A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis.

Authors:  Peter W Angus; Scott J Patterson; Simone I Strasser; Geoffrey W McCaughan; Edward Gane
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

9.  HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis.

Authors:  Bruno Roche; Cyrille Feray; Michele Gigou; Anne Marie Roque-Afonso; Jean Louis Arulnaden; Valerie Delvart; Elisabeth Dussaix; Catherine Guettier; Henri Bismuth; Didier Samuel
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

10.  Liver transplantation in European patients with the hepatitis B surface antigen.

Authors:  D Samuel; R Muller; G Alexander; L Fassati; B Ducot; J P Benhamou; H Bismuth
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.